CClinicalTrials.gg
WithdrawnNCT04928989WORKCITUpdated Jul 11, 2022

Convergence Dialogue Meeting With or Without Neck-specific Exercise Promoting Work Ability

An interventional study of convergence dialogue meeting in Workplace, sponsored by Linkoeping University. Withdrawn at 2 sites in Sweden. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-07-11.

Sponsored by Linkoeping University · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Lack of funding.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to convergenge dialogue meeting with or without neck-specific exercise. The main outcome measure is work ability, measured via the Work Ability Score.

Read the detailed description

Background: Collaboration between employees, manager and occupational health expert is needed to promote work ability. One effective method is a convergence dialogue meeting (CDM). Based on the existing work situation, factors are identified in these meetings that can strengthen the employee's work ability and opportunities for a sustainable working life. A combination of workplace and individual interventions is recommended for best effect. Neck-specific exercise (NSE) is the method with the most evidence for neck problems. NSE in evidence based form has not been investigated for work-related neck pain. More knowledge is needed regarding how CDM can be combined with NSE because clear guidelines are lacking on the best intervention for increased work ability in the case of neck problems. Also lacking are evaluations of digitally distributed CDMs and NSE with support from a web-based program for the current population. The aim of the proposed randomized controlled study is to investigate the contribution of NSE with four visits to a physiotherapist and support from a web-program in addition to three digital CDMs promoting the work situation.

Methods: The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to CDM with or without NSE. The main outcome measure is work ability, measured via the Work Ability Score. Secondary outcome measures are pain, function, health-related quality of life, work absenteeism and presenteeism, work-related factors, and cost-effectiveness. Pathophysiological aspects regarding inflammation and stress markers measured in blood and saliva will be studied, as will muscular changes measured by microdialysis. Interviews are planned with both employees and managers.

Discussion: The goal of the study is to contribute to improved rehabilitation, strengthened work ability, and a sustainable working life for employees with neck problems.

02

Conditions studied

  • Workplace

Keywords

  • Neck pain
  • Workplace
  • Counceling
  • Exercise
  • Internet-based intervention
03

In context

Lead sponsor

Linkoeping University is the lead sponsor of 189 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Self-reported neck problems that the person experiences as troublesome, affecting ability to perform work, and lasting at least 4 weeks.
  • Neck problems as being predominant.
  • Current neck pain ≥ 3 on the numeric rating scale (0-10) [53, 55].
  • Persons of working age, 18-65 years, who have a permanent job.
  • Neck problems clinically verified through a clinical examination to ensure study criteria are met.
  • Answers the baseline questionnaire and attends the first intervention visit.
  • Confirms being motivated to participate and completes and signs informed consent, including approval, to contact their immediate supervisor regarding a CDM.

Exclusion criteria

Exclusion Criteria:

  • Red flags and illness/injury that are contraindicated for or hinder exercise or may be confounding factors for the results, such as severe cardiovascular/lung disease, malignancy, severe rheumatic disease, severe neurological disease, spinal cord injury, diagnosed severe mental illness, drug or alcohol abuse, neck surgery, neck fracture or dislocation, severe cervical radiculopathy, myelopathy, general body pain (e.g., fibromyalgia, Ehlers-Danlos syndrome, generalized osteoarthritis).
  • Known pregnancy.
  • Cannot understand/communicate in Swedish and thus would be unable to understand information in the study.

For blood samples (not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added: increased tendency to bleed and use of blood thinners.

For the subgroup for microdialysis (n = 30, consecutively asked, 15 persons/group; not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added:

  • Patients who cannot imagine refraining from non-steroid anti-inflammatory drugsduring 2 days before microdialysis may not participate in the microdialysis part of the study.
  • Hypersensitivity to anesthetic and antibiotics.
  • Increased tendency to bleed and use of blood-thinning drugs.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Convergence dialogue meeting

    Digital counceling with convergence dialogue tripartite meeting. will be conducted in accordance with work dialogue for return to work. Workplace dialogue among employee with neck problems, an expert in the work environment, and the immediate manager. The purpose of the conversations is, in open dialogue, to reach a common understanding of the situation and identify possible interventions to maintain or improve the employee´s work ability.

    Other: convergence dialogue meeting

  • Experimental
    Neck-specific exercise in addition to convergence dialogue meeting

    Neck-specific exercise with digital web-based support and four visits to a physiotherapist. Neck-specific exercise will be performed based on a well-structured framework of neck-specific exercise for facilitation of deep neck muscles, increased muscle coordination, improved neck posture and increased neck muscle endurance. Plus additional convergence dialogue meeting as treatment arm no 1.

    Other: convergence dialogue meeting

Interventions

  • Otherconvergence dialogue meeting

    Digital counceling with convergence dialogue tripartite meeting. will be conducted in accordance with work dialogue for return to work. Workplace dialogue among employee with neck problems, an expert in the work environment, and the immediate manager. The purpose of the conversations is, in open dialogue, to reach a common understanding of the situation and identify possible interventions to maintain or improve the employee´s work ability.

06

What researchers measure

Primary outcomes

  1. Work Ability Score

    Current work ability compared to when it was at its best

    Time frame: Change in work Ability Score from baseline, to every month until the 15 month follow-up

Secondary outcomes

  1. Intensity of pain and bothersomeness

    neck pain intensity and bothersomeness, headache intensity on a numeric ratin scale.

    Time frame: change from baseline to 3 month and 15 month follow-up

  2. Frequency of pain, symtoms and medications

    Frequency of pain, pain medication, neck stiffness, numbness/tingling into the arms, having problems lifting the arms, dizziness, sleep, concentration

    Time frame: change from baseline to 3 month and 15 month follow-up

  3. Neck specific function

    Neck Disability Index

    Time frame: change from baseline to 3 month and 15 month follow-up

  4. Symptom satisfaction

    Symptom satisfaction according to Cherkin

    Time frame: change from baseline to 3 month and 15 month follow-up

  5. Exercise/physical activity level

    Exercise/physical activity level

    Time frame: change from baseline to 3 month and 15 month follow-up

  6. Health related quality of life

    EQ-5D-3L

    Time frame: change from baseline to 3 month and 15 month follow-up

  7. Fear avoidance

    Fear avoidance beliefs questionnaire

    Time frame: change from baseline to 3 month and 15 month follow-up

  8. self rated function

    Patient Specific Functional Scale

    Time frame: change from baseline to 3 month follow-up

  9. work situation

    description of work tasks

    Time frame: description and change from baseline to 3 month and 15 month follow-up

  10. self-rated work situation regarding working hours

    working hours

    Time frame: description and change from baseline to 3 month and 15 month follow-up

  11. perceived exertion at work

    Borg ratings of perceived exertion

    Time frame: change from baseline to 3 month and 15 month follow-up

  12. Work ability

    work ability index

    Time frame: change from baseline to 3 month and 15 month follow-up

  13. Sick leave,

    sick leave numbers of days/ month

    Time frame: change from baseline to 3 month and 15 month follow-up

  14. Presenteeism

    presenteeism number of days/ month and Stanford presenteeism scale

    Time frame: change from baseline to 3 month and 15 month follow-up

  15. Effort-Reward Imbalance

    Effort Reward Imbalance questionnaire

    Time frame: change from baseline to 3 month and 15 month follow-up

  16. Demand-control, support

    Swedish Demand Control Support Questionnaire which is a short version of the Job centent questionnaire

    Time frame: change from baseline to 3 month and 15 month follow-up

  17. Risk identifaction at work

    Structured multidisciplinary work evaluation tool

    Time frame: change from baseline to 3 month and 15 month follow-up

  18. work adaptation

    work adaptation such as self strategies to be able to work

    Time frame: change from baseline to 3 month and 15 month follow-up

  19. Time sitting

    Time sitting at work and during leisure time

    Time frame: change from baseline to 3 month and 15 month

  20. Anxiety and depression

    Hospital Anxiety and Depression scale

    Time frame: change from baseline to 3 month and 15 month follow-up

  21. Overall outcome

    Global rating of change scale

    Time frame: change from baseline to follw-ups at 3 month and 15 month

  22. Fulfilment of treatment expectation

    Fulfilment of treatment expectation, have your expectations been fulfilled: yes, yes partly, no

    Time frame: 3 month and 15 month related to the patient own expectations

  23. Satisfaction with the caregiver visits in the study

    Patient enablement questionnaire

    Time frame: 3 month, 15 month

  24. Adverse events/ side-effects

    adverese events/ side effects of treatment in the study

    Time frame: 3 month, 15 month

  25. Cost-effectiveness

    Cost effectiveness through calculation of direct costs; quantity and type of care (inside and outside the study also including drugs related to pain) from registers and from questionnaires, indirect costs;mainly production loss from registers and from questionnaire.

    Time frame: From the time period between baseline to 15 month follow-up

  26. Saliva samples and blood samples

    Inflammation markers, stress markers. The samples will be taken in the morning on an empty stomach. Saliva will be collected with Salivette. Venous blood samples (10-20 ml) from the elbow fold will be collected in EDTA tubes. identification and quantification of proteins.

    Time frame: change from baseline to 3 month in a subgroup of the RCT population, all those who agree and are without contra indication

  27. Microdialysis, tissue changes in the middle Trapezius

    Biomechanical changes interstitialli in M. Trapezius. Through microdialysis technology, it is possible to monitor biochemical changes interstitially in the tissue. The technique involves the exchange of substances via diffusion between the tissue and a diaphragmatic catheter inserted into the tissue and flushed by a fluid (perfusate) that is similar in chemical composition to the fluid in the muscle interstitium.

    Time frame: baseline, 3 month, subgroup of the RCT population approximately n=30

  28. Interview study of employers

    employers experience with interventions and their impact on work ability, health and work situation

    Time frame: 3 month, subgroup of the RCT population, n=20 approximately

  29. Interview with managers

    Interviews with managers regarding the experience of the convergence dialogue meeting

    Time frame: 3 month, approximately n=20

  30. Observation study

    Observation study regarding the interaction between the participants in the converge dialogue meeting. Qualitative data in natural clinical settings of CDMs will be collected through video recordings (≈ 20) to find the meaning of what happen and the interactions during the dialogue. Tripartiate dialogue between patient, manager and care giver regarding the work situation and how to improve it.

    Time frame: During the 3 month treatment period at tripartiate convergence dialogue meeting

  31. Health related quality of life on vertical visual analogue scale

    EQ thermometer

    Time frame: change from baseline to 3 month and 15 month follow-up

  32. self-rated work situation regarding stress at work

    work stress

    Time frame: description and change from baseline to 3 month and 15 month follow-up

  33. self-rated work situation regarding work environment

    work environment

    Time frame: description and change from baseline to 3 month and 15 month follow-up

  34. self-rated work situation regarding satisfaction at work

    workplace and work satisfaction

    Time frame: description and change from baseline to 3 month and 15 month follow-up

  35. self-rated work situation regarding self-rated work performance

    work performance

    Time frame: description and change from baseline to 3 month and 15 month follow-up

  36. self-rated work situation regarding neck position at work

    neck position

    Time frame: description and change from baseline to 3 month and 15 month follow-up

Other outcomes

  1. profession

    Swedish standard for work classification

    Time frame: baseline

  2. Background data

    Age, gender, education, family situation, pain duration, expectations, smoking history

    Time frame: baseline

  3. ICD 10 code

    ICD 10 code decided after a physical examination

    Time frame: baseline

  4. Pain screening

    Örebro musculoskeletal pain screeing questionnaire

    Time frame: baseline

  5. screening for "yellow flags"- behaviour factors at risk

    START neck screening tool

    Time frame: baseline

  6. Treatment outside the study

    treatment outside the study

    Time frame: 3 month, 15 month

  7. profession, open question

    open question regarding profession

    Time frame: description and change from baseline, 3 month and 15 month follow-up

07

Study locations

2 sites
  • Anneli Peolsson
    Linkoping, Ostergotland 58183, Sweden
  • Dep. Medical and Health Sciences, Physiotherapy
    Linköping, Östergötland 58183, Sweden
08

References and documents

Individual participant data

Plan to share: No — The data is protected by the Swedish health secrets acts and the European General Data Protection Regulation. Data will be presented on a group level without possibility for individual identification.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04928989
Lead sponsor
Linkoeping University
Responsible party
Anneli Peolsson (Professor, PhD, MSc PT, MSc HRMD, Linkoeping University) — Principal investigator
First posted
Jun 18, 2021
Start date
May 2022 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 11, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion